Pancreatic Cancer Research

ResearcherNational Research CouncilActive in the last 2 years

Luca Cardone

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-8184-2856; OpenAlex author ID A5050871239. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
16
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 3

  1. Enhancing PDAC therapy: Decitabine-olaparib synergy targets KRAS-dependent tumors. Last author DOI 10.1016/j.isci.2025.111842↗
  2. Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer Patients. Co-author DOI 10.2147/cmar.s483151↗
  3. Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1158/0008-5472.can-19-0187↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Carla Mottini · 2 shared papers, 2019–2025 · strength 0.31
  2. Giorgia Anastasio · 1 shared paper, 2025 · strength 0.25
  3. Claudia Fuchs · 1 shared paper, 2025 · strength 0.20
  4. Alfredo Budillon · 1 shared paper, 2025 · strength 0.20
  5. Violeta V. Stoyanova-Beninska · 1 shared paper, 2025 · strength 0.20
  6. Stephen Bigelsen · 1 shared paper, 2025 · strength 0.20
  7. Alfredo Carrato · 1 shared paper, 2025 · strength 0.20
  8. Ilse Rooman · 1 shared paper, 2025 · strength 0.20
  9. Evelyn Hewitt · 1 shared paper, 2025 · strength 0.20
  10. Alessandro Carugo · 1 shared paper, 2019 · strength 0.07
  11. Ya’an Kang · 1 shared paper, 2019 · strength 0.07
  12. Hideo Tomihara · 1 shared paper, 2019 · strength 0.07
  13. Jason B. Fleming · 1 shared paper, 2019 · strength 0.07
  14. Michael P. Kim · 1 shared paper, 2019 · strength 0.07
  15. Davide Melisi · 1 shared paper, 2019 · strength 0.07
  16. Giulio Francesco Draetta · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.